Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ABBOTT LABORATORIES | 209,401 | reported | 24 Mar 2006 | tx 20+928,075−408,023 |
| VERTEX PHARMACEUTICALS INC / MA | 34,797 | reported | 24 Feb 2026 | tx 362+5,425,157−5,195,235 |
| Odyssey Therapeutics, Inc. | 28,698 | reported | 11 May 2026 | tx 9+662,881−303,985 |
| QUEST DIAGNOSTICS INC | 6,000 | reported | 29 May 2018 | tx 30+24,570−16,230 |
| MILLENNIUM PHARMACEUTICALS INC | 0 | reported | 14 May 2008 | tx 2+35,000−35,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2026 | PURCHASE | Odyssey Therapeutics, Inc. | 5,000 | 20.00 USD | first after silence |
| 11 May 2026 | CONVERSION | Odyssey Therapeutics, Inc. | 28,698 | — | |
| 11 May 2026 | EXERCISE | Odyssey Therapeutics, Inc. | 2,963 | — | |
| 11 May 2026 | TAX_WITHHOLDING | Odyssey Therapeutics, Inc. | 17 | 18.00 USD | |
| 11 May 2026 | CONVERSION | Odyssey Therapeutics, Inc. | 79,166 | — | deriv |
| 11 May 2026 | CONVERSION | Odyssey Therapeutics, Inc. | 100,000 | — | deriv |
| 11 May 2026 | CONVERSION | Odyssey Therapeutics, Inc. | 96,002 | — | deriv |
| 07 May 2026 | GRANT_AWARD | Odyssey Therapeutics, Inc. | 626,220 | 0.00 USD | deriv |
| 11 May 2026 | EXERCISE | Odyssey Therapeutics, Inc. | 28,800 | — | deriv |
| 24 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 3,547 | 485.11 USD | |
| 18 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,964 | 483.75 USD | |
| 17 Feb 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 8,269 | 0.00 USD | |
| 22 Jan 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 9,012 | 0.00 USD | |
| 04 Dec 2025 | EXERCISE | VERTEX PHARMACEUTICALS INC / MA | 1 | 91.05 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 7,899 | 445.56 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 10,360 | 453.34 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 15,681 | 452.20 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 5,809 | 451.20 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 5,880 | 449.84 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,320 | 448.78 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,152 | 447.05 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,070 | 455.22 USD | |
| 03 Dec 2025 | EXERCISE | VERTEX PHARMACEUTICALS INC / MA | 63,781 | 86.52 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 4,469 | 440.40 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,320 | 441.26 USD |
1 purchase reported after at least 12 months of silence — most recent on 08 May 2026.